These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31020628)

  • 21. Hyperuricemia contributes to the faster progression of diabetic kidney disease in type 2 diabetes mellitus.
    Bartáková V; Kuricová K; Pácal L; Nová Z; Dvořáková V; Švrčková M; Malúšková D; Svobodová I; Řehořová J; Svojanovský J; Olšovský J; Bělobrádková J; Kaňková K
    J Diabetes Complications; 2016; 30(7):1300-7. PubMed ID: 27324705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-transplant Hyperuricemıa as a Cardıovascular Risk Factor.
    Erkmen Uyar M; Sezer S; Bal Z; Guliyev O; Tutal E; Kulah E; Genctoy G; Ozdemir Acar N; Haberal M
    Transplant Proc; 2015 May; 47(4):1146-51. PubMed ID: 26036541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.
    Akalin E; Ganeshan SV; Winston J; Muntner P
    Transplantation; 2008 Sep; 86(5):652-8. PubMed ID: 18791445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperuricemia and chronic kidney disease: to treat or not to treat.
    Piani F; Sasai F; Bjornstad P; Borghi C; Yoshimura A; Sanchez-Lozada LG; Roncal-Jimenez C; Garcia GE; Hernando AA; Fuentes GC; Rodriguez-Iturbe B; Lanaspa MA; Johnson RJ
    J Bras Nefrol; 2021; 43(4):572-579. PubMed ID: 33704350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum uric acid predicts cardiovascular mortality in male peritoneal dialysis patients with diabetes.
    Xia X; Zhao C; Peng FF; Luo QM; Zhou Q; Lin ZC; Yu XQ; Huang FX
    Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):20-6. PubMed ID: 26712272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low serum uric acid levels increase the risk of all-cause death and cardiovascular death in hemodialysis patients.
    Li M; Ye ZC; Li CM; Zhao WB; Tang H; Liu X; Peng H; Lou TQ
    Ren Fail; 2020 Nov; 42(1):315-322. PubMed ID: 32223483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions.
    Eyupoglu S; Eyupoglu D; Kendi-Celebi Z; Akturk S; Tuzuner A; Keven K; Sengul S
    Transplant Proc; 2017 Apr; 49(3):505-508. PubMed ID: 28340822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of cardiac valvular calcification on all-cause and cardiovascular mortality in maintenance hemodialysis patients.
    Li M; Ye ZC; Li CM; Zhao WB; Tang H; Liu X; Peng H; Lou TQ
    Int Urol Nephrol; 2020 May; 52(5):943-951. PubMed ID: 32239335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study.
    Chang YH; Lei CC; Lin KC; Chang DM; Hsieh CH; Lee YJ
    Diabetes Metab Res Rev; 2016 Sep; 32(6):557-64. PubMed ID: 26590369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.
    Liu WC; Hung CC; Chen SC; Yeh SM; Lin MY; Chiu YW; Kuo MC; Chang JM; Hwang SJ; Chen HC
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):541-8. PubMed ID: 22300737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperuricemia and chronic kidney disease: an enigma yet to be solved.
    Dousdampanis P; Trigka K; Musso CG; Fourtounas C
    Ren Fail; 2014 Oct; 36(9):1351-9. PubMed ID: 25112538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.
    Lebensburger JD; Cutter GR; Howard TH; Muntner P; Feig DI
    Pediatr Nephrol; 2017 Sep; 32(9):1565-1573. PubMed ID: 28382567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between hyperuricemia and the risk of mortality in patients with osteoarthritis: A study based on the National Health and Nutrition Examination Survey database.
    Hao Y; Tang X; Xu F
    PLoS One; 2024; 19(5):e0302386. PubMed ID: 38713669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
    Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
    Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
    Kimura K; Hosoya T; Uchida S; Inaba M; Makino H; Maruyama S; Ito S; Yamamoto T; Tomino Y; Ohno I; Shibagaki Y; Iimuro S; Imai N; Kuwabara M; Hayakawa H; Ohtsu H; Ohashi Y;
    Am J Kidney Dis; 2018 Dec; 72(6):798-810. PubMed ID: 30177485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum uric acid levels and mortality in the Japanese population: the Yamagata (Takahata) study.
    Kamei K; Konta T; Ichikawa K; Sato H; Suzuki N; Kabasawa A; Suzuki K; Hirayama A; Shibata Y; Watanabe T; Kato T; Ueno Y; Kayama T; Kubota I
    Clin Exp Nephrol; 2016 Dec; 20(6):904-909. PubMed ID: 26779905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
    Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
    J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels.
    Gondouin B; Jourde-Chiche N; Sallee M; Dou L; Cerini C; Loundou A; Morange S; Berland Y; Burtey S; Brunet P; Guieu R; Dussol B
    Nephron; 2015; 131(3):167-74. PubMed ID: 26426087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum uric acid independently predicts cardiovascular events in advanced nephropathy.
    Kanbay M; Yilmaz MI; Sonmez A; Solak Y; Saglam M; Cakir E; Unal HU; Arslan E; Verim S; Madero M; Caglar K; Oguz Y; McFann K; Johnson RJ
    Am J Nephrol; 2012; 36(4):324-31. PubMed ID: 23007099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.